Detalles de la búsqueda
1.
Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy.
Int J Mol Sci
; 22(11)2021 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34070597
2.
Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activity.
Int J Mol Sci
; 22(20)2021 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34681730
3.
PIM2 survival kinase is upregulated in a p53-dependent manner in cells treated with camptothecin or co-treated with actinomycin D and nutlin-3a.
Arch Biochem Biophys
; 655: 26-36, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30096294
4.
The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.
Int J Cancer
; 137(10): 2332-42, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25975224
5.
Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study.
J Transl Med
; 13: 304, 2015 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26376850
6.
The SIPA1 -313A>G polymorphism is associated with prognosis in inoperable non-small cell lung cancer.
Tumour Biol
; 36(2): 1273-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25352027
7.
Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes.
Chem Biol Interact
; 392: 110946, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38460933
8.
Radiotherapy-related changes in serum proteome patterns of head and neck cancer patients; the effect of low and medium doses of radiation delivered to large volumes of normal tissue.
J Transl Med
; 11: 299, 2013 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24304975
9.
The influence of XPD, APE1, XRCC1, and NBS1 polymorphic variants on DNA repair in cells exposed to X-rays.
Mutat Res
; 755(1): 42-8, 2013 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23669291
10.
DNA Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients.
Cancers (Basel)
; 15(20)2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37894339
11.
Common Variants in Osteopontin and CD44 Genes as Predictors of Treatment Outcome in Radiotherapy and Chemoradiotherapy for Non-Small Cell Lung Cancer.
Cells
; 12(23)2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38067149
12.
Germline Variants in Angiogenesis-Related Genes Contribute to Clinical Outcome in Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
; 14(7)2022 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35406617
13.
Association of Genetic Variants in ANGPT/TEK and VEGF/VEGFR with Progression and Survival in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy or Radiochemotherapy.
Cancers (Basel)
; 12(6)2020 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32526933
14.
Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity.
Cell Signal
; 69: 109552, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32032660
15.
The Alzheimer's disease-associated TREM2 gene is regulated by p53 tumor suppressor protein.
Neurosci Lett
; 681: 62-67, 2018 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29842899
16.
Actinomycin D and nutlin-3a synergistically promote phosphorylation of p53 on serine 46 in cancer cell lines of different origin.
Cell Signal
; 27(9): 1677-87, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25989210
17.
Identification of serum proteome components associated with progression of non-small cell lung cancer.
Acta Biochim Pol
; 61(2): 325-31, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24872961
Resultados
1 -
17
de 17
1
Próxima >
>>